Randomized trials in vulnerable populations

Area of Science:

• Clinical Research Ethics
• Vulnerable Populations in Research
• Regulatory Science

Background:

• Clinical trials involving vulnerable populations present unique ethical considerations due to potential diminished autonomy.
• Despite these challenges, such research is essential for determining effective medical interventions and ensuring patient safety.

Purpose of the Study:

• To identify specific challenges in conducting randomized clinical trials in vulnerable populations.
• To propose actionable solutions for overcoming these identified challenges.
• To emphasize the need for global collaboration among all stakeholders.

Main Methods:

• Identification of six key challenges in vulnerable population clinical trials.
• Analysis of macro issues including scope, funding, and investigator capacity.
• Examination of research ethics review, informed consent, regulatory hurdles, and adverse event reporting.

Main Results:

• Six distinct challenges in clinical trials for vulnerable groups were identified.
• Potential solutions were proposed for each challenge, addressing both macro and micro issues.
• The importance of stakeholder awareness and collaboration was highlighted.

Conclusions:

• Addressing challenges in vulnerable population trials requires a multi-faceted, collaborative approach.
• Improved quality, quantity, safety, and relevance of trials for vulnerable persons globally is achievable.
• Continuous engagement from all stakeholders is vital for ethical and effective clinical research.